ELC Group appoints former TOPRA president
Dr Paolo Biffignandi joins ELC Group’s Advisory Board
Dr Biffignandi, a renowned physician, with PhDs in endocrinology and pharmacology, is a Fellow of TOPRA, as well as an Overseas Fellow of the Royal Society of Medicine (UK). He brings more than 30 years' experience in Regulatory Affairs and pharmacovigilance to ELC Group’s Advisory Board.
Commenting on his appointment, Dr Biffignandi said: 'ELC Group is the industry expert, and I'm pleased to accept this opportunity to join its Advisory Board and to contribute to its continued strategic success.'
You may also like
Regulatory
MoonLake Immunotherapeutics faces Securities Class Action after disastrous Phase III trial results
The announcement about the trial results for the product candidate sonelokimab, a highly anticipated treatment for patients with skin disease, saw MoonLake investors' shares fall by about 90%, prompting an investigation into whether or not they were misled
Regulatory
NAD+ supplement claims under scrutiny as Niagen Bioscience wins landmark advertising case
The National Advertising Division (NAD) has ruled against Reus Research over unsupported NAD+ product claims, reinforcing that oral NAD+ ingestion lacks scientific backing and affirming Niagen’s clinically proven approach